Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Discovery

• Publication date

  2015-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/2159-8290.CD-13-1050PMID 25653093PMCID PMC6010310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ETS fusion genes in prostate cancer.

  2014cited by this paper
• Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation

  2014cited by this paper
• ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.

  2013cited by this paper
• PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells

  2013cited by this paper
• ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss

  2013cited by this paper
• ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.

  2013cited by this paper
• Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

  2013cited by this paper
• Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy.

  2013cited by this paper
• The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair

  2013cited by this paper
• Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines

  2012cited by this paper
• ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data

  2012cited by this paper
• DNA damage checkpoints in stem cells, ageing and cancer

  2012cited by this paper
• CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

  2012cited by this paper
• Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs

  2011cited by this paper
• COP1 is a tumour suppressor that causes degradation of ETS transcription factors

  2011cited by this paper
• Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

  2011cited by this paper
• CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

  2011cited by this paper
• PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

  2011cited by this paper
• p53-family proteins and their regulators: hubs and spokes in tumor suppression

  2010cited by this paper
• Enhanced H2AX Phosphorylation, DNA Replication Fork Arrest, and Cell Death in the Absence of Chk1

  2010cited by this paper
• Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo

  2010cited by this paper
• An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

  2010cited by this paper
• Integrative genomic profiling of human prostate cancer.

  2010cited by this paper
• Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

  2009cited by this paper
• Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

  2009cited by this paper
• The DNA-damage response in human biology and disease

  2009cited by this paper
• Expanded Roles for Chk1 in Genome Maintenance*

  2008cited by this paper
• Recurrent gene fusions in prostate cancer

  2008cited by this paper
• DNA Damage Detection and Repair Pathways—Recent Advances with Inhibitors of Checkpoint Kinases in Cancer Therapy

  2008cited by this paper
• Chk1 Haploinsufficiency Results in Anemia and Defective Erythropoiesis

  2008cited by this paper
• Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45

  2008cited by this paper
• Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts.

  2008cited by this paper
• Role of the TMPRSS2-ERG gene fusion in prostate cancer.

  2008cited by this paper
• Activation of Targeted Necrosis by a p53 Peptide

  2007cited by this paper
• Integrative molecular concept modeling of prostate cancer progression

  2007cited by this paper
• ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.

  2007cited by this paper
• CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo

  2007cited by this paper
• Chk1 regulates the density of active replication origins during the vertebrate S phase

  2007cited by this paper
• Cross-talk between Chk1 and Chk2 in double-mutant thymocytes

  2007cited by this paper
• The Mammalian DNA Replication Elongation Checkpoint: Implication of Chk1 and Relationship with Origin Firing as Determined by Single DNA Molecule and Single Cell Analyses

  2007cited by this paper
• The DNA damage response: ten years after.

  2007cited by this paper
• Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

  2007cited by this paper
• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006cited by this paper
• Participation of p 53 Protein in the Cellular Response to DNA Damage 1

  2006cited by this paper
• PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.

  2005cited by this paper
• Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress.

  2005cited by this paper
• Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms

  2005cited by this paper
• Chk1-Dependent S-M Checkpoint Delay in Vertebrate Cells Is Linked to Maintenance of Viable Replication Structures

  2005cited by this paper
• Inhibition of Human Chk1 Causes Increased Initiation of DNA Replication, Phosphorylation of ATR Targets, and DNA Breakage

  2005cited by this paper
• The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

  2005cited by this paper
• Lack of PTEN sequesters CHK1 and initiates genetic instability.

  2005cited by this paper
• Chk1 is haploinsufficient for multiple functions critical to tumor suppression.

  2004cited by this paper
• Cell-cycle checkpoints and cancer

  2004cited by this paper
• Chk1 and Chk2 kinases in checkpoint control and cancer.

  2003cited by this paper
• Pten Dose Dictates Cancer Progression in the Prostate

  2003cited by this paper
• Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.

  2002cited by this paper
• Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability.

  2001cited by this paper
• Candidate tumour suppressor genes at 11q23–q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis

  2001cited by this paper
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.

  2000cited by this paper
• CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers

  1999cited by this paper
• CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers.

  1999cited by this paper
• Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer.

  1999cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.

  1997cited by this paper
• p53 and chemosensitivity

  1996cited by this paper
• EWS‐FLI‐1 and EWS‐ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor

  1995cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper

• RAD21 promotes oncogenesis and lethal progression of prostate cancer

  2024cites this paper
• Bibliometric analysis of PTEN in neurodevelopment and neurodegeneration

  2024cites this paper
• Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients

  2024cites this paper
• Identification of hub genes and their correlation with infiltration of immune cells in MYCN positive neuroblastoma based on WGCNA and LASSO algorithm

  2022cites this paper
• HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET

  2022cites this paper
• Targeting PEA3 transcription factors to mitigate small cell lung cancer progression

  2022cites this paper
• In Vivo Models for Prostate Cancer Research

  2022influential citation
• Expression and prognosis analyses of PEA3 subfamily in head and neck squamous cell carcinoma via integrated bioinformatics

  2021cites this paper
• Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors

  2020cites this paper
• Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53.

  2020cites this paper
• Function and regulation of the PEA3 subfamily of ETS transcription factors in cancer.

  2020cites this paper
• Comparative RNA-seq analysis reveals dys-regulation of major canonical pathways in ERG-inducible LNCaP cell progression model of prostate cancer

  2019cites this paper
• Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era.

  2019cites this paper
• Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors

  2019cites this paper
• Patient-matched analysis identifies deregulated networks in prostate cancer to guide personalized therapeutic intervention

  2019cites this paper
• Fonctions et régulations de la kinase CHK1 dans l'hématopoïèse normale et leucémique

  2019cites this paper
• Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2

  2018cites this paper
• Phosphorylation of ETV4 at Ser73 by ERK kinase could block ETV4 ubiquitination degradation in colorectal cancer.

  2017cites this paper
• Chk1 Promotes DNA Damage Response Bypass following Oxidative Stress in a Model of Hydrogen Peroxide-Associated Ulcerative Colitis through JNK Inactivation and Chromatin Binding

  2017cites this paper
• Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma

  2017cites this paper
• Prostate-derived ETS factor improves prognosis and represses proliferation and invasion in hepatocellular carcinoma.

  2017cites this paper
• Distinct outcomes of CRL–Nedd8 pathway inhibition reveal cancer cell plasticity

  2016cites this paper
• Etude de nouvelles fonctions de la protéine checkpoint kinase 1 (Chk1) au cours de la différenciation myéloïde normale et leucémique

  2016cites this paper
• CHK1 and replicative stress in T-cell leukemia: Can an irreverent tumor suppressor end up playing the oncogene?

  2016cites this paper
• Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression

  2016cites this paper
• Roles and regulations of the ETS transcription factor ELF4/MEF

  2016cites this paper
• Effective intra‐S checkpoint responses to UVC in primary human melanocytes and melanoma cell lines

  2016cites this paper
• The TMPRSS2–ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition

  2015cites this paper